A hypothesis of synergism: The interrelationship of T3 and insulin to disturbances in metabolic homeostasis

Medical Hypotheses

Volumn 59, Issue 6, 2002, Pages 660-666

  Kim, S R ^a,c   Tull, E S ^a   Talbott, E O ^a   Vogt, M T ^a,b   Kuller, L H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GUANOSINE TRIPHOSPHATE; INSULIN; LIOTHYRONINE; MEMBRANE RECEPTOR; PYRUVATE KINASE; CELL SURFACE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

CELL MEMBRANE; CHOLESTEROL SYNTHESIS; DIABETES CONTROL; ENERGY BALANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HOMEOSTASIS; HORMONE SYNTHESIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC DISORDER; MOLECULAR BIOLOGY; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSPORT KINETICS; BIOLOGICAL MODEL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

GTP-BINDING PROTEINS; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC DISEASES; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRIIODOTHYRONINE;

EID: 0036901722     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00211-6     Document Type: Article

References (60)

1. De Fronzo R. A., Tobin J. D., Andres R. Glucose clamp techniques: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
2. Rewers M., Hanmman R. F. Risk factors for NIDDM. In: Diabetes in America, 2nd Edn. 1995: 179-220.
3. Pilkis S. J., El-Maghrabi M. R., Claus T. H. Fructose-2,3-biphosphate in control of hepatic gluconeogenesis: From metabolites to molecular genetics. Diabetes Care 1990; 13: 588-599.
4. Groop I. C., Kaankuri M., Schalin J. C. Association between polymorphism of the glycogen synthase gene and NIDDM. N Engl J Med 1993; 328: 110-114.
5. Sherrat H. A. S., Bartlett K. Metabolic regulation. In: R. D. Cohen, B. Lewis, K. G. M. M. Albert, A. M. Denmann (eds). The Metabolic and Molecular Basis of Acquired Diseases. London: Baillie're Tindall, 1990: 300-320.
6. Groot L. J., Jameson J. L. Mechanism of thyroid hormone action. In: Endocrinology, 3rd Edn. Leslie Degroot, Philadelphia, PA: W. B. Saunders, 1995: 1-64. pp. 583-601.
7. Granner D. K., Pikis S. The genes of hepatic glucose metabolism. J Biol Chem 1990; 265: 10173-10182.
8. Weinstein S. P., Watts J., Graves P. N., Haber R. S. Stimulation of glucose transport by thyroid hormone in ARL.15 cells: Increased abundance of glucose transporter protein and messenger RNA. Endocrinology 1990; 126: 1421-1429.
9. Meyers D. S., Skwish S., Kenneth E. J., Kienzle D. B., Arbeeny C. 3-Adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomologus monkeys. J Clin Endocrinol Metab 1997; 82: 395-401.
10. Garcia-Sainz A., Litosch I., Hoffman B. Effect of thyroid state on a- and b-cathecholamine responsiveness of hamster. Biochim Biphys Acta 1981; 678: 334-341.
11. Pan D. A., Lilliolja S., Krikrtos A. D., Miller M. R., Bauer L. A., Borgadus C. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997: 83-988.
12. Rapiejko P. J., Watkins D. C., Ros M., Malbon C. C. Thyroid hormones regulate G-protein B subunit mRNA expression in Vivo. J Biol Chem 1989; 264: 16183-16189.
13. Randle P. J. et al. Concept of the glucose-fatty acid cycle. Ciba Found Colloquia Endocrinol 1964: 15-19.
14. Kelly E. D., Mandarino L. J. Fuel selection in human skeletal muscle in insulin resistance. Diabetes 2000; 49: 677-683.
15. Verhaegen M., Mariash C. N., Krug F. Nunez: Cyclic AMP and lipogenesis in fat cells from thyroidectomized rats. J Mol Cell Endocrinol 1979; 14: 167-169.
16. Freake H. C., Schwartz H. L., Oppenheimer J. H. The regulation of lipogenesis and its contribution to thermogenesis. Endocrinology 1989; 125: 2868-2874.
17. Melbone C. C., Moreno F. J., Cabell R. J., Fain J. N. Cyclic nucleotides and lipogenesis in fat cell from thyroidectomized rats. J Biol Chem 1978; 253: 671-678.
18. Forciea M. A., Schwartz H. L., Towle H. C., Mariash C. N., Kaiser F. E., Oppenheimer J. H. Thyroid Hormone-Carbohydrate Interaction in Rat. 67: 1739-1747.
19. O'Brien R. M., Watson R. Regulation of fetal muscle development by thyroxin. Acta Anat 1994; 149(1): 21-30.
20. Pittman C. S. The effects of diabetes mellitus on thyroid physiology. Thyroid Today 1981; 4: 1-4.
21. Ohara H., Kobayshi, Shiraishi M., Wada T. Thyroid function of the aged as viewed from the pituitary thyroid system. Endocrinol JPN 1979; 21: 377-384.
22. Lewis G. F., Alessi C. A., Imperial J. G., Refetoff S. Low serum thyroxin index in ambulatory elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metabolism 1991; 972X: 7304-0843.
23. Segal J., Ingbar S. H. In vivo stimulation of sugar uptake in rat thymocyte. J Clin Inv 1985; 76: 1575-1580.
24. Gilman A. G. G-proteins and dual control of adenylate cyclase. Cell 1984; 36(40): 577-579.
25. Styler L., Bourne H. R. G-proteins: A family of signal transducers. Ann Rev Cell Biol 1986; 2: 391-419.
26. Khalfallah Y., Fages S., LAviile M. Regulation of UCP-2 and 3 mRNA expression during lipid infusion in human skeletal muscle and subcutaneous adipose tissue. Diabetes 2000; 49: 25-31.
27. Boss O., Hagen T., Lowell B. B. Uncoupling proteins 2 and 3; potential regulators of mitochondrial energy metabolism. Diabetes 2000; 49: 143-156.
28. Pendersen O. Decreased tolbutamide-stimulated insulin secretion in healthy subjets with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 1998; 47: 598-605.
29. Agular-Bryan J. Molecular biology of ATP-sensitive potassium channels. Endocr Res 1999; 20: 101-136.
30. Orlowsky J., Lingrell J. B. Thyroid and glucocorticoid homornes regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes. J Bio Chem 1990; 265: 3462-3470.
31. Subramaniant A., Jones W. K., Gulick J., Wert S., Neuman J., Robbins J. Tissue-specific regulation of the a-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 1991; 256: 24613-24620.
32. Houselay M. D., Kilgour E. Cyclic nucleotide phosphodiesterase in liver. In: J. A. Beavo, M. D. Houselay (eds). Cycleic Nucleotide Phosphodiesterase: Structure, Regulation and Drug Action. Chichester, UK: Wiley, 1990: 185-223.
33. Kitabchi A. E., Umpierrez G. E., Murphy M. B., Barret E. J. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24: 131-151.
34. Raasmaja A., Larsen P. R. A1 and B-adrenergi agents cause synergistic stimulation of the lodothyronine Deiodinase in rat brown adiposities. Endocrinology 1989; 125: 2502-2509, 1999.
35. Revell V. P., Pescini R., Muzzin P., Seydoux J. Change in B1- and B2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats. Biochem J 1991; 277: 625-629.
36. Sharp G. W. The adenylate cyclase-cAMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia 1979; 16: 287-296.
37. -/- mice. Diabetes 48:1987-1994.
38. Philip D. L., Caddy S., Illic V., Fielding B. A., Frayn K. N., Borth wick A. C. Intramuscular triglyceride and muscle insulin sensitivity: Evidence for relationship in nondiabetic subjects. Metabolisms 1996; 45: 947-950.
39. Kyte J. Molecular considerations relevant to the mechanism of active transport. Nature 1981; 292: 201-204.
40. Hoppner W., Seitz H. J. Effect of thyroid hormones on glucokinase gene transcription in rat liver. J Biol Chem 1989; 264: 20647.
41. Wall S. R., van den M. F. Thyroid hormone stimulates expression of 6-phosphofructo-2-kinase in rat liver. FEBS Lett 1989; 267: 211-214.
42. Swierczyski J., Mitchell D. A., Reinhold D. S. Triiodothyronine-induced accumulations of malic enzyme, fatty acid synthase, acetyl-coA carboxylase, and their mRNAs are blocked by protein kinase inhibitors. Transcription is the affected step. J Biol Chem 1991; 266: 17459-17466.
43. Simonet W. S., Ness G. C. Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormone receptor. Proc Natl Acad Sci USA 1987; 84: 3420-3425.
44. Strobl W., Gorder N. L., Lin Ly. et al. Role of thyroid hormones in apolipoprotein A-1 gene expression in rat liver. J Clin Invest 1990; 85: 659-667.
45. Thomson A. L., Cooney G. J. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes 2000; 49: 1761-1765.
46. Goodpaster B. H., Theate F. L., Slmoneau J. A., Kelley D. E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-1595.
47. Olesky J. M., Farquhar J. W., Raven G. M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551-560.
48. Redgrave T. G., Snibson D. A. Clearance of chylomicron triacylglycerol and cholesteryl ester from plasma of streptozin-induced diabetic and hypercholesterolemic hypothyroid rats. Metabolism 1977; 26: 493-503.
49. Hiroes Y. H., Lindsey R. L., Yoshitaka N., Johnson J. H., Unger R. H. Defective fatty acid-mediated b-cell compensation in Zucker diabetic fatty acid rate pathogenic implication for obesity-dependent diabetes. J Biol Chem 1996; 217: 5633-5637.
50. Shupnik Ardissen L. J., Meskell M. J. T3 regulation of TSH subunit gene transcription is proportional to T3 nuclear receptor occupancy. Endocrinology 1986; 118: 367-371.
51. Weyer C., Borgadus C., Pratley E. P. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose. Diabetes 1999; 48: 2197-2203.
52. Barter P., Millerl, Larruoy D., Galitky J., Berdan M., Louvert J. P., Langin D. Uncoulping proteins 2mRNA expression during very-low-calorie-diet in obese premenopausal women. J Clin Endocrinol Metab 1998; 83: 2450-2453.
53. Schrauen P., Xia J., Bogardus C., Partley R. E., Ravissen E. Skeletal muscle uncoupling protein3 expression is a determination of energy expenditure in Pima Indians. Diabetes 1999; 48: 146-149.
54. Nyholin B., Qu Z., Kaal A. Evidence of an increased number of type-2b muscle fibers in insulin resistant first-degree relatives of patients with NIDDM. Diabetes 1997; 46: 1822-1828.
55. Warrik H. M., Spudich J. A. Myosin structure and function in cell motility. Ann Rev Cell Biol 1987; 3: 379-421.
56. He J., Watkins S., Kelley D. E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001; 50: 817-823.
57. Kelley D. E., Goodpaster B., Wing R. R., Simoneau J. A. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol 1999; 277: E1130-E1141.
58. Simoneeau J. A., Kelley D. E. Altered glycolytic and oxidative capacities of skeletal muscle contributes to insulin resistance in NIDDM. J Appl Physiol 1997; 83: 166-171.
59. Simoneau J. A., Collberg S. R., Theate F. L., Kelley D. E. Skeletal muscle glycolytic and oxidative enzyme capacities of skeletal muscle composition in obese women. FASEB J 1996: 9273-9278.
60. Kim S. R., Talbott E. O., Tull E. S., Vogt M. T., Kuller L. H. Assessment of metabolic homeostasis. Med. Hypothesis (submitted).